3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
28
Gynecologic
4
Thoracic
3
Genitourinary
3
Gastrointestinal
3
Dermatologic
3
Sarcoma
2
Plasma cell
1
Other hematologic neoplasm
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
22
Mouth Neoplasms
17
Oropharyngeal Neoplasms
16
Carcinoma
16
Laryngeal Neoplasms
15
Hypopharyngeal Neoplasms
13
Nasopharyngeal Carcinoma
9
Salivary Gland Neoplasms
6
Melanoma
6
Thyroid Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
4
Carcinoma, Renal Cell
4
Uterine Cervical Neoplasms
3
Thyroid Cancer, Papillary
3
Endometrial Neoplasms
3
Colorectal Neoplasms
3
Carcinosarcoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Adenocarcinoma, Follicular
3
Stomach Neoplasms
2
Pheochromocytoma
2
Paranasal Sinus Neoplasms
2
Paraganglioma
2
Colonic Neoplasms
2
Carcinoma, Merkel Cell
2
Carcinoma, Basal Cell
2
Interventions
pembrolizumab
31
Nivolumab
11
Ipilimumab
6
spartalizumab
5
cemiplimab
5
atezolizumab
5
Gemcitabine
4
Docetaxel
4
durvalumab
3
budigalimab
3
avelumab
3
Oxaliplatin
3
Leucovorin
3
Irinotecan
3
Immune Checkpoint Inhibitors
3
Fluorouracil
3
Cyclophosphamide
3
Cetuximab
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
obinutuzumab
2
lenvatinib
2
fludarabine
2
epacadostat
2
X-Rays
2
Paclitaxel
2
Immunoglobulin G
2
Cisplatin
2
Capecitabine
2
Biopsy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Triple Negative Breast Neoplasms
×
Specimen Handling
×
Head & Neck
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled